Dystonia Drug Market will Reach US$ 1,493.68 Million by 2034 at a CAGR of 5.46%
The Dystonia Drug Market is witnessing steady growth as healthcare providers and pharmaceutical companies continue to focus on improving treatment options for patients suffering from dystonia, a neurological movement disorder characterized by involuntary muscle contractions, repetitive movements, and abnormal postures. …